ClinicalTrials.gg
RecruitingNCT04075539FLEXCALUpdated Nov 20, 2025

Home-based Cycling for People With Lumbar Spinal Stenosis

A Phase 3 interventional study of Home-based cycling program and usual care in Symptomatic Lumbar Spinal Stenosis, sponsored by Assistance Publique - Hôpitaux de Paris. Recruiting at 1 site in France. Open to participants aged 50 Years and older. Per ClinicalTrials.gov, last updated 2025-11-20.

Sponsored by Assistance Publique - Hôpitaux de Paris · Phase 3, Interventional, and Treatment

From the registry’s dates

  • Started Feb 2025; still recruiting 1 year 9 months later.
Phase
Phase 3
Study type
Interventional
Enrollment
302
Allocation
Randomized
Ages
50 Years and older
Sex
All
01

Study summary

The main objective of the study is to compare the efficacy on back-specific activity limitations at 4 months after-randomisation of home-based cycling using connected ergometric bicycles associated with usual care to usual care.

Read the detailed description

Lumbar spinal stenosis is a prevalent and disabling condition in elderly people. Lumbar spinal stenosis results in back and leg pain when standing and walking (radicular claudication), while symptoms regress in sitting position. The inability to stand or walk significantly impairs functioning and health-related quality of life of elders, and has an important healthcare cost.

The 2 main treatment options for lumbar spinal stenosis are conservative or surgical treatments. Previous data suggested that laminectomy may be more effective on pain and function than conservative therapy. However, the benefit-risk balance of surgery should be carefully considered in this population with numerous co-morbidities, and evidence is inconsistent. Therefore, conservative therapy is usually the first line option. Data regarding exercise therapy are scarce. Flexion-based exercises are usually recommended. A pilot study suggested that flexion-based endurance training program, namely cycling, could be an effective and safe method to improve pain, function and health-related quality of life in elderly people with chronic lumbar pain. However, barriers to adhering to the program were detected and might have influenced clinical endpoints. Non-pharmacological interventions in spinal conditions are not 'one-size-fits-all' and measures to enhance adherence have to be applied.

The hypothesis is that home-based cycling using connected ergometric bicycles associated with usual care could be more effective than usual care in reducing back-specific activity limitations at 4 months in people with lumbar spinal stenosis.

02

Conditions studied

  • Symptomatic Lumbar Spinal Stenosis

Keywords

  • Lumbar spinal stenosis
  • Neurogenic claudication
  • Low back pain
  • Exercise therapy
  • Endurance training
  • Cycling
  • Randomized trial
03

In context

Spinal Stenosis

458 studies on the registry are indexed under Spinal Stenosis; 105 are open to participants now.

This study's planned enrollment of 302 is above the median of 80 across 281 interventional studies indexed under Spinal Stenosis.

Browse Spinal Stenosis studies →

Lead sponsor

Assistance Publique - Hôpitaux de Paris is the lead sponsor of 3,592 studies on the registry; 1,033 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
50 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • age ≥ 50 year-old
  • radicular claudication (i.e. walking-induced low back, buttock and/or leg pain, relieved in siting and/or lumbar flexion positions) diagnosed by a physician
  • MRI or CT-scan findings consistent with LSS reported on a written radiology report provided by a board-certified radiologist or a resident in radiology

Exclusion criteria

Exclusion Criteria:

  • inability to speak and/or read French language
  • inability or refusal to perform ergometric bicycle at home
  • patients already having an ergometric bicycle at home
  • history of lumbar spine surgery in the previous 12 months
  • cognitive disorders
  • severe neurologic or vascular disorders involving the lower limbs
  • to a rehabilitation program assessed by medical examination
  • people under tutorship or curatorship
  • protected adults
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Phase 3
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
302 participants (estimated)

Study arms

  • Experimental
    Home-based cycling program associated to usual care

    Other: Home-based cycling program

  • Other
    Outpatient physiotherapy

    Other: usual care

Interventions

  • OtherHome-based cycling program

    Usual care (i.e. standardized prescription of 6 sessions of outpatient physiotherapy), and * 1 supervised session of cycling aimed at explaining how to use the connected ergometric bicycle and at designing a personalized home-based cycling program * a 12-month home-based cycling program using connected ergometric bicycles which intensity and dose are self-determined * 3 phone or email contacts with a care provider to deliver positive feedbacks and encouragements

  • Otherusual care

    A prescription of 6 sessions of outpatient physiotherapy

06

What researchers measure

Primary outcomes

  1. Change in back-specific activity limitations

    Mean change from baseline in mean back-specific activity limitations in the previous month using the self-administered Oswestry Disability Index (ODI) total score (0 no limitations and 100 maximal limitations).

    Time frame: 4 months after-randomization

Secondary outcomes

  1. Change in maximal walking distance

    Mean change from baseline in mean maximal walking distance (meters) using an adapted version of the self-paced walking-test

    Time frame: 4 months post-randomization

  2. Change in lumbar pain

    Mean change from baseline in mean low back pain intensity in the previous 48 hrs on a self-administered 11-point pain numeric rating scale (0 no pain and 100 maximal pain)

    Time frame: 4, 6 and 12 months post-randomization

  3. Change in radicular pain

    Mean change from baseline in mean radicular pain intensity in the previous 48 hrs on a self-administered 11-point pain numeric rating scale (0 no pain and 100 maximal pain)

    Time frame: 4, 6 and 12 months post-randomization

  4. Change in the physical component of health-related quality of life

    Mean change from baseline in the mean physical component of health-related quality of life assessed by the physical component score of the self-administered 12-Item Short Form Survey (9.95 worst possible and 70.02 best possible)

    Time frame: 4, 6 and 12 months post-randomization

  5. Change in lumbar spinal stenosis-specific activity limitations

    Mean change from baseline in mean LSS-specific activity limitations using the physical function subscore of the self-administered Zurich Claudication Questionnaire (1 no limitations and 4 maximal limitations)

    Time frame: 4, 6 and 12 months post-randomization

  6. Change in back-specific activity limitations

    Mean change from baseline in mean spine-specific activity limitations assessed by the total score of the self-administered Oswestry Disability Index (0 no limitations and 100 maximal limitations)

    Time frame: 6 and 12 months post-randomization

  7. Percentage of patients who undergo spinal surgery

    Self-reported spinal surgery for lumbar spinal stenosis

    Time frame: From baseline to 12 months post-randomization

07

Study locations

1 of 1 sites recruiting
  • Assistance Publique - Hôpitaux de Paris, Service de Rééducation et de Réadaptation de l'Appareil Locomoteur et des Pathologies du Rachis, Hôpital Cochin
    Paris, Île-de-France Region 75014, France
    Recruiting
08

References and documents

Publications

  • Nguyen C, Boutron I, Roren A, Baron G, Pauwels C, Lefevre-Colau MM, Poiraudeau S, Dupeyron A, Coudeyre E, Rannou F. Home-based cycling using connected ergometric bicycles for people with lumbar spinal stenosis (FLEXCAL): Protocol for a randomised trial. Ann Phys Rehabil Med. 2021 Mar;64(2):101351. doi: 10.1016/j.rehab.2019.12.006. Epub 2020 Jan 23. No abstract available. PubMed 31982599 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 20, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04075539
Collaborators
URC-CIC Paris Descartes Necker Cochin
Responsible party
Sponsor
First posted
Aug 30, 2019
Start date
Feb 10, 2025
Primary completion
Jun 2027 (estimated)
Completion
Feb 2028 (estimated)
Last update
Nov 20, 2025

Study contacts

Christelle Nguyen, MD, PhD
Contact
christelle.nguyen2@aphp.fr
+33 1 58 41 25 35
Laetitia PEAUDECERF, PhD
Contact
laetitia.peaudecerf@aphp.fr
+33 1 58 41 12 13
Christelle Nguyen, MD, PhD
principal investigator · Université de Paris, Faculté de Médecine Paris Descartes
François Rannou, MD, PhD
study director · Université de Paris, Faculté de Médecine Paris Descartes
Isabelle Boutron, MD, PhD
study chair · Université de Paris, Faculté de Médecine Paris Descartes

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion